Genomic regions of coxsackievirus B3 associated with cardiovirulence
- PMID: 9210047
Genomic regions of coxsackievirus B3 associated with cardiovirulence
Abstract
The molecular basis for cardiovirulence in the coxsackievirus B3 (CVB3) genome was examined in a murine model of acute myocarditis. Infectious cDNAs representing a highly cardiovirulent coxsackievirus B3 (CVB3m) and a noncardiovirulent (CVB30) virus were used to construct infectious chimeric cDNAs. Assays of the resulting recombinant viruses for cardiovirulence in adolescent male CD-1 mice showed that the 5' nontranslated region (5' NTR) of the CVB3m genome plays the major role in determining cardiovirulence and that the genomic region encoding the capsid proteins has a minor additive effect in increasing cardiovirulence. Nucleotide sequences in the 5' NTR of CVB3m and CVB30 differ at 23 positions; 14 are located in four stemloop motifs of the secondary structure and may influence the cardiovirulent phenotype by regulating RNA or protein synthesis. A comparison of predicted amino acid sequences of capsid proteins in CVB3m and CVB30 identified two amino acids as potential candidate contributors to cardiovirulence, i.e., amino acids at positions A207 (Asn-Asp) in the puff structure of the E-F loop of VP2 and A566 (Gln-Glu) in the C terminal of VP3 at the external surface. The data from this study and published literature support the conclusion that cardiovirulence of a CVB3 can depend on several regions of the genome.
Similar articles
-
Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.J Virol. 2000 May;74(10):4787-94. doi: 10.1128/jvi.74.10.4787-4794.2000. J Virol. 2000. PMID: 10775617 Free PMC article.
-
The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.J Infect Dis. 2003 May 15;187(10):1552-61. doi: 10.1086/374877. Epub 2003 Apr 30. J Infect Dis. 2003. PMID: 12721935
-
Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3.J Med Virol. 1997 Jul;52(3):258-61. J Med Virol. 1997. PMID: 9210033
-
Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.Trends Microbiol. 1996 May;4(5):175-9. doi: 10.1016/0966-842x(96)10026-3. Trends Microbiol. 1996. PMID: 8727596 Review.
-
Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.Int J Med Microbiol. 2008 Jan;298(1-2):127-34. doi: 10.1016/j.ijmm.2007.08.010. Epub 2007 Sep 25. Int J Med Microbiol. 2008. PMID: 17897883 Review.
Cited by
-
Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.J Virol. 2000 May;74(10):4787-94. doi: 10.1128/jvi.74.10.4787-4794.2000. J Virol. 2000. PMID: 10775617 Free PMC article.
-
Molecular Aspects of Myocarditis.Curr Infect Dis Rep. 2000 Aug;2(4):308-314. doi: 10.1007/s11908-000-0008-x. Curr Infect Dis Rep. 2000. PMID: 11095870
-
A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.J Virol. 2005 Jul;79(14):9285-95. doi: 10.1128/JVI.79.14.9285-9295.2005. J Virol. 2005. PMID: 15994822 Free PMC article.
-
A Single Mutation in the Cryptic AUG (cAUG) Affects In Vitro Translation and Replication Efficiencies and In Vivo Virulence of Coxsackievirus B3 (CVB3).Curr Microbiol. 2022 Aug 16;79(10):288. doi: 10.1007/s00284-022-02986-3. Curr Microbiol. 2022. PMID: 35972696
-
Biological significance of a human enterovirus B-specific RNA element in the 3' nontranslated region.J Virol. 2002 Oct;76(19):9900-9. doi: 10.1128/jvi.76.19.9900-9909.2002. J Virol. 2002. PMID: 12208967 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources